These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 22982372)

  • 1. Pharmacological modulation of brain activity in a preclinical model of osteoarthritis.
    Upadhyay J; Baker SJ; Rajagovindan R; Hart M; Chandran P; Hooker BA; Cassar S; Mikusa JP; Tovcimak A; Wald MJ; Joshi SK; Bannon A; Medema JK; Beaver J; Honore P; Kamath RV; Fox GB; Day M
    Neuroimage; 2013 Jan; 64():341-55. PubMed ID: 22982372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models.
    Baragi VM; Becher G; Bendele AM; Biesinger R; Bluhm H; Boer J; Deng H; Dodd R; Essers M; Feuerstein T; Gallagher BM; Gege C; Hochgürtel M; Hofmann M; Jaworski A; Jin L; Kiely A; Korniski B; Kroth H; Nix D; Nolte B; Piecha D; Powers TS; Richter F; Schneider M; Steeneck C; Sucholeiki I; Taveras A; Timmermann A; Van Veldhuizen J; Weik J; Wu X; Xia B
    Arthritis Rheum; 2009 Jul; 60(7):2008-18. PubMed ID: 19565489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gait analysis and pain response of two rodent models of osteoarthritis.
    Ferland CE; Laverty S; Beaudry F; Vachon P
    Pharmacol Biochem Behav; 2011 Jan; 97(3):603-10. PubMed ID: 21111752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological modulation of movement-evoked pain in a rat model of osteoarthritis.
    Chandran P; Pai M; Blomme EA; Hsieh GC; Decker MW; Honore P
    Eur J Pharmacol; 2009 Jun; 613(1-3):39-45. PubMed ID: 19376109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults.
    Kivitz A; Fairfax M; Sheldon EA; Xiang Q; Jones BA; Gammaitoni AR; Gould EM
    Clin Ther; 2008 Dec; 30(12):2366-77. PubMed ID: 19167595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The analgesic actions of centrally administered celecoxib are mediated by endogenous opioids.
    Rezende RM; Dos Reis WG; Duarte ID; Lima PP; Bakhle YS; de Francischi JN
    Pain; 2009 Mar; 142(1-2):94-100. PubMed ID: 19186002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rofecoxib 12.5 mg, rofecoxib 25 mg, and celecoxib 200 mg in the treatment of symptomatic osteoarthritis: results of two similarly designed studies.
    Smugar SS; Schnitzer TJ; Weaver AL; Rubin BR; Polis AB; Tershakovec AM
    Curr Med Res Opin; 2006 Jul; 22(7):1353-67. PubMed ID: 16834834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celecoxib compared with sustained-release paracetamol for osteoarthritis: a series of n-of-1 trials.
    Yelland MJ; Nikles CJ; McNairn N; Del Mar CB; Schluter PJ; Brown RM
    Rheumatology (Oxford); 2007 Jan; 46(1):135-40. PubMed ID: 16777855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatiotemporal gait compensations following medial collateral ligament and medial meniscus injury in the rat: correlating gait patterns to joint damage.
    Kloefkorn HE; Jacobs BY; Loye AM; Allen KD
    Arthritis Res Ther; 2015 Oct; 17():287. PubMed ID: 26462474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of COX-2 by celecoxib in the canine groove model of osteoarthritis.
    Mastbergen SC; Marijnissen AC; Vianen ME; Zoer B; van Roermund PM; Bijlsma JW; Lafeber FP
    Rheumatology (Oxford); 2006 Apr; 45(4):405-13. PubMed ID: 16287921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional and structural imaging of pain-induced neuroplasticity.
    Seifert F; Maihöfner C
    Curr Opin Anaesthesiol; 2011 Oct; 24(5):515-23. PubMed ID: 21822136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of rofecoxib 12.5 mg and celecoxib 200 mg in two similarly designed osteoarthritis studies.
    Birbara C; Ruoff G; Sheldon E; Valenzuela C; Rodgers A; Petruschke RA; Chang DJ; Tershakovec AM
    Curr Med Res Opin; 2006 Jan; 22(1):199-210. PubMed ID: 16393445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The analgesic and anti-inflammatory effect of WIN-34B, a new herbal formula for osteoarthritis composed of Lonicera japonica Thunb and Anemarrhena asphodeloides BUNGE in vivo.
    Kang M; Jung I; Hur J; Kim SH; Lee JH; Kang JY; Jung KC; Kim KS; Yoo MC; Park DS; Lee JD; Cho YB
    J Ethnopharmacol; 2010 Sep; 131(2):485-96. PubMed ID: 20643199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing the efficacy of cyclooxygenase 2-specific inhibitors in treating osteoarthritis: appropriate trial design considerations and results of a randomized, placebo-controlled trial.
    Gibofsky A; Williams GW; McKenna F; Fort JG
    Arthritis Rheum; 2003 Nov; 48(11):3102-11. PubMed ID: 14613272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of cartilage defect at medial femoral condyle in early osteoarthritis of the knee.
    Kamei G; Sumen Y; Sakaridani K
    Magn Reson Imaging; 2008 May; 26(4):567-71. PubMed ID: 18083319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of rofecoxib, celecoxib, and acetaminophen in patients with osteoarthritis of the knee. A combined analysis of the VACT studies.
    Schnitzer TJ; Weaver AL; Polis AB; Petruschke RA; Geba GP;
    J Rheumatol; 2005 Jun; 32(6):1093-105. PubMed ID: 15940774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of CNS pain circuitry by intravenous and sublingual doses of buprenorphine.
    Upadhyay J; Anderson J; Baumgartner R; Coimbra A; Schwarz AJ; Pendse G; Wallin D; Nutile L; Bishop J; George E; Elman I; Sunkaraneni S; Maier G; Iyengar S; Evelhoch JL; Bleakman D; Hargreaves R; Becerra L; Borsook D
    Neuroimage; 2012 Feb; 59(4):3762-73. PubMed ID: 22119647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity of gait parameters to the effects of anti-inflammatory and opioid treatments in knee osteoarthritis patients.
    Boyer KA; Angst MS; Asay J; Giori NJ; Andriacchi TP
    J Orthop Res; 2012 Jul; 30(7):1118-24. PubMed ID: 22179861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analgesic effects of intrathecally administered celecoxib, a cyclooxygenase-2 inhibitor, in the tail flick test and the formalin test in rats.
    Nishiyama T
    Acta Anaesthesiol Scand; 2006 Feb; 50(2):228-33. PubMed ID: 16430547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a metalloproteinase inhibitor on osteochondral angiogenesis, chondropathy and pain behavior in a rat model of osteoarthritis.
    Mapp PI; Walsh DA; Bowyer J; Maciewicz RA
    Osteoarthritis Cartilage; 2010 Apr; 18(4):593-600. PubMed ID: 20067755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.